USPTO serial 79150591
CTRS
Reviewed by CopyMark Law Group
Reg. 4783860Status 404
- Filing date
- Status date
- Registration date
- Aug 4, 2015
- Examiner
- COLEMAN, CIMMERIAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CTRS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-92100 BOULOGNE BILLANCOURT, FR
F-92100 BOULOGNE BILLANCOURT, FR
F-92100 BOULOGNE BILLANCOURT, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the treatment of biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; dietetic substances and foods for medical use, namely, drinks adapted for medical use; antibiotics; capsules for medicines, namely, capsules for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; stem cells for medical use; drugs for medical use, namely, pharmaceutical preparations for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; medicines for human medicine, namely, pharmaceutical preparations for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions cancer; bacteriological preparations for medical purposes; biological preparations for medical use, namely, biological preparations for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; chemical preparations for medical or pharmaceutical use, namely, for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematology and cancer; diagnostic products for medical use, namely, medical diagnostic reagents | SECTION 71 - CANCELLED | — |
| 042 | Medical services featuring evaluations, estimates and research in the field of science; research and development in the field of medicine and biotechnology; research and development for others in the medical and pharmaceutical field; scientific laboratory services in the medical field; scientific research for medical purposes; biological research; bacteriological research; chemical research | SECTION 71 - CANCELLED | — |
| 044 | Medical services related to biliary insufficiency, cell therapy, inflammatory conditions and disease, hematology and cancer; health counseling services related to biliary insufficiency, cell therapy, inflammatory conditions and disease, hematology and cancer; consultancy in the field of pharmaceutical products; medical information; information on pharmaceutical products; medical analysis services relating to the treatment of patients affected by biliary insufficiency, cell therapy, inflammatory conditions and diseases, hematology-related and cancer-related conditions and diseases; medical diagnostic services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LABORATOIRES C.T.R.S.
- Other trademarks owned by LABORATOIRES C.T.R.S.
- Other trademarks owned by LABORATOIRES C.T.R.S.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CTRS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 1, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 1, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 20, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 18, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Nov 18, 2022 | INPC | INVALIDATION PROCESSED | — |
| Oct 18, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 18, 2022 | C71T | CANCELLED SECTION 71 | — |
| Aug 4, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 7, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 15, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 5, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 6, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 6, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 4, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 4, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 12, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 6, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 19, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 19, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 29, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 29, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 29, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 13, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 11, 2015 | ALIE | ASSIGNED TO LIE | — |
| Mar 23, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 24, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 24, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 24, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 27, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 27, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 27, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 26, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 18, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 18, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 15, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |